Pam Andrews Homeopathy

06/05/2026

New bunch of remedies in the post

06/05/2026

With the winter months coming on I thought we could do a deep dive into a popular well known remedy that is a must-have in your homeopathic kit - and that is RHUS TOX.

Made from the plant Poison Ivy, this remedy is a polycrest, which in homeopathy speak means - it has a multitude of uses.

So lets look at what happens should you brush past a poison ivy plant
- you would get itchy, very itchy.

So this is a remedy we can look at for itchy skin. However there are lots of remedies for itchy skin. What makes Rhus Tox unusual is the itchiness is better for heat. So itchy skin relieved by a hot bath or shower, think Rhus Tox.

Can be also useful for Chicken Pox, Shingles, and Eczema.

Another keynote of Rhus Tox is it has an affinity for Muscle-Skeletal and they feel better for movement. However they are often stiff and sore on first getting up. Think of an old dog gets up from his bed, creaks his way to his food bowl, however once he's warmed up, is happy to go walkies. I've felt abit like that lately, Ive got an achy hip that gets me in the morning, and I find Rhus Tox keeps me moving and relieves the aches.

Another keynote is Restless and Stiff, they feel compelled to move to get relief. For example husband may be sick in bed with the flu, and even though he is lying and just about "dying", there is still a restless element.

So think of Rhus Tox for any arthritic pains, rheumatism and fibromyralgia. The pain is particularly exacerbated with the coming of cold damp weather.

Remember it is less about the diagnoses that guides us to the remedy, and more about the symptoms, that pertain to you!

Winter time brings the incessant reminders to 'get your flu shot', i think Ive heard about 5 on spotify since writing this!!

No need, you can treat with Homeopathic remedies

Rhus Tox is a great remedy for Flus and I used it often for the treatment of Covid.

Flus where the muscles are achy and stiff, feel better sitting by the fire and a thirst for cold water. An interesting confirming keynote is a red tip on the end of the tongue. I find the tongue a great confirming indicator when choosing between remedies.

What are your go to remedies during Flu Season?

02/05/2026

Misnomer #554
When you give a remedy you need to prescribe with intention 🙏.
This is not correct, as it is playing into the placebo argument.
You either have the right remedy or the wrong one, its as simple as that.

02/05/2026

A beautiful review ☺️

"I have seen Pam on 3 occasions and on each occasion she spent time to really get to know the issues affecting me. She was inquisitive, curious and listened to what I had to say. She carefully considered the treatment options and on all occasions prescribed exactly what I needed. Her treatments have transformed my life and supported me through difficult times. I am very grateful to Pam and will continue to see her. I highly recommend her."

30/04/2026

This is criminal

Regulators Warn ADHD Drug Can Trigger Homicidal Thoughts—Parents and Consumers Need to be Informed

CCHR demands urgent reforms to ensure families are fully informed in real time about life-threatening side effects of ADHD psychotropics—a $20 billion market—as millions remain unaware of new global warnings linking one drug to homicidal thoughts.

By Jan Eastgate, President CCHR International

CCHR International has called for urgent measures to ensure consumers and parents of children treated for “Attention Deficit Hyperactivity Disorder” (ADHD) are fully informed of new drug regulatory agency warnings about serious side effects associated with ADHD prescription drugs—especially homicidal thoughts. New alerts from Australia and Germany now warn that atomoxetine, a widely prescribed “non-stimulant” ADHD drug, patented as Strattera, can cause homicidal ideation—adding to its existing warnings about suicidal behavior in children and young adults.

In June 2025, Australia’s Therapeutic Goods Administration (TGA) updated the product information for atomoxetine hydrochloride to include a special warning and precautions about “severe cases” of “physical assault, or threatening behavior and thoughts of harming others” in children taking the drug. A separate warning issued in May emphasized that the risk was not limited to children, highlighting “aggressive behavior including homicidal ideation.” The product information further notes that “aggressive behavior or hostility was more frequently observed in clinical trials among children, adolescents, and adults treated with atomoxetine compared to placebo.”

In February, Germany’s Federal Institute for Drugs and Medical Devices published a report, Atomoxetine: New warnings about serotonin syndrome and homicidal thought, confirming that the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency concluded there is a “possible connection” between atomoxetine and cases of serotonin syndrome—a potentially fatal condition causing toxicity—as well as physical assaults, threatening behavior, and homicidal thoughts.

Serotonin syndrome, or serotonin toxicity, is a potentially life-threatening condition resulting from prescription drugs such as antidepressants that build up high levels of serotonin in the central nervous system.

These alarming developments follow a March 2025 action by the U.S. Food and Drug Administration (FDA), which had Glenmark Pharmaceuticals “voluntarily recall” 1.48 million bottles of atomoxetine from the market after tests revealed a potential carcinogen in multiple batches.

The stakes are high: the Atomoxetine Hydrochloride Market was valued at $1.2 billion in 2024, while the overall U.S. ADHD drug market now tops $20 billion annually.

Other Serious Adverse Effects

New studies confirm that atomoxetine’s risks are a small part of much larger concerns with ADHD drugs:

A September 2024 study published in the American Journal of Psychiatry found that patients taking higher doses of ADHD drugs were more than five times as likely to develop psychosis or mania. Lead researcher Dr. Lauren Moran emphasized that a clear warning label is needed to alert prescribers and patients to this risk.
In 2023, Swedish researchers identified a 23% increased risk of heart disease among individuals using ADHD drugs for more than five years compared to non-users.

The FDA has also acknowledged that ADHD stimulant drugs can cause addiction, even when taken exactly as prescribed. This prompted the agency to add this information to its black box warning. The U.S. Drug Enforcement Administration (DEA) classifies ADHD stimulants in the same category of highly addictive substances as OxyContin and fentanyl, warning that they can lead to “severe psychological dependence.”

Renowned Danish researcher and physician Peter C. Gøtzsche warned that the short-term harms of ADHD drugs can include tics, twitches, obsessive-compulsive behaviors, aggression, and suicidal or homicidal ideation. Stimulants can also cause children to become apathetic or indifferent by suppressing normal mental and behavioral activity. In some studies, more than half of the children on stimulants developed depression and compulsive, meaningless behaviors.

According to FDA Medication Guides, ADHD drugs can cause new or worsening behavior or thought problems, aggression, hostility, and psychotic symptoms in both children and adults.

In 2005, Eli Lilly added a black box warning to Strattera (the branded version of atomoxetine) about suicidal thoughts in children and adolescents.

Despite all this, millions of Americans continue to be prescribed these drugs. CCHR, using IQVIA data, reports that in 2020, more than 6.3 million U.S. adults aged 18–65+ were prescribed stimulants for ADHD, including 340,000 seniors over 65. More than 3.1 million children and teens up to age 17 were also prescribed ADHD stimulants—shockingly, this included over 58,000 children aged five or younger, even though these drugs are not FDA-approved for this age group.

A Subjective Diagnosis

Consumers and parents are often unaware that ADHD is diagnosed subjectively—there is no objective test or scan to confirm it. A new study by researchers at the University of Copenhagen reviewed 292 randomized controlled drug trials for adult ADHD and found widespread methodological flaws: reliance on self-diagnosis, automated tools, and staff with minimal training. Over half the studies included participants with other psychiatric diagnoses, muddying the data. The researchers concluded these flaws undermine the scientific reliability of many ADHD drug trials.

This mirrors a 2022 exposé that debunked the “chemical imbalance” myth used to justify antidepressant use—a theory used for decades in pharmaceutical marketing to sell drugs for a non-existent “chemical defect.”

As SciTech Daily reported on the Copenhagen study: “With adult ADHD diagnoses soaring, often driven by online content, the findings raise serious concerns about research reliability and treatment accuracy. If flawed science is shaping how millions are treated, are we getting ADHD all wrong?”

Indeed, there are no medical tests to confirm that ADHD is a neurobiological condition, despite drug ads implying otherwise. For adults, the “symptoms” range from impulsiveness and poor time management to excessive activity, low frustration tolerance, and trouble coping with stress—in other words, behaviors common to millions.

The adult ADHD market has become a major profit driver for drug companies, psychiatrists, and other prescribing physicians. Fierce Pharma highlighted in 2015 that ADHD drug use among adults was expanding nearly twice as fast as the overall market.

Dr. Allen Frances, former chair of the American Psychiatric Association’s Diagnostic & Statistical Manual of Mental Disorders (DSM) IV task force, has publicly described the surge in ADHD, autism, and childhood bipolar disorder diagnoses as “three false epidemics.” He remains critical of psychiatry’s ever-expanding boundaries and its tendency to medicalize normal human behavior.

Symptoms for children and adolescents are equally subjective and include:

“Often fails to give close attention to details or makes careless mistakes in school work….”

“Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort….”

“Often fidgets with or taps hands or feet or squirms in seat.”
“Often unable to play or engage in leisure activities quietly.”

In January 2025, The Journal of the Royal Society of Medicine warned: “The real epidemic out there is the epidemic of ADHD diagnosing and prescribing… Lacking proven biological anchoring, syndromal categories are susceptible to cultural trends regarding over-medicalization and societal contagion… We are witnessing a spectacular rise from nothing in the societal profile of ‘adult ADHD’, in part fueled by self-administered checklists… Once something is declared real, it becomes real in its consequences.”

Professor Gøtzsche adds that one cannot “have” ADHD: “We can have a car or a dog, but not ADHD. It’s not something that exists in nature that can attack us like bacteria can. It’s just a name for a certain behavior.” He also notes there is no genetic association with ADHD, and the claims about ADHD brains being smaller have been thoroughly debunked.

He says psychiatrists “are totally absorbed in the drug-focused paradigm.”

The Need for an Informed System

Consumers and parents deserve a transparent system that alerts them to new international warnings and known risks, especially when those risks include psychosis, addiction, cardiac issues, suicidal or homicidal thoughts. As the World Health Organization and United Nations have warned, mental health systems worldwide remain overly reliant on a narrow biomedical approach that too often defaults to drugging.

The idea that a drug prescribed to millions of children and adults could induce homicidal behavior is nothing short of astonishing—yet parents and consumers remain largely in the dark. This is a complete breakdown of a system that should uphold the highest standard of informed consent. CCHR insists that regulators, prescribers, and manufacturers must be held accountable for ensuring that clear, timely warnings reach every patient and parent before a pill is ever taken. Anything less is a betrayal of public trust—and leaves lives needlessly at risk.

29/04/2026

AI bots prescribing SSRIs after a 9 question questionaire. What could possibly go wrong?
🤦‍♀️
Tell me your thoughts?

28/04/2026

If you are needing help with Neurodivergence in the family, I am one of the admin of this group with over 4000 members

26/04/2026

AI is creeping into every sector and taking over like mould in the basement.
And Homeopathy is no exception.
Ive had complex cases which I have carefully unraveled, slowly making progress and the Mum, getting impatient, sends me a 'suggustion' clearly from chatgpt. 🤦‍♀️
Choosing the remedy is more than putting a bunch of symptoms into software and picking the top match.
If we are treating the person, then we need to understand them.
Why do they do what they do.
What are their coping strategies
What has contributed to this condition, to bring it to this point.
At the end of the day, do we want to lose what we all crave, and this is connection.
Thoughts?